Literature DB >> 15812482

Introducing new vaccines into developing countries: obstacles, opportunities and complexities.

John Clemens1, Luis Jodar.   

Abstract

Infectious diseases are thought to account for nearly 25% of all deaths worldwide, and extract a disproportionate toll in developing countries. Moreover, infectious diseases are now appreciated to be major causes of the poverty and economic underdevelopment that characterize the world's poorest countries. Development and deployment of new vaccines to prevent infectious diseases in developing countries have therefore become high priorities in the global health agenda.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15812482     DOI: 10.1038/nm1225

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  18 in total

1.  Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger.

Authors:  Bruce Y Lee; Tina-Marie Assi; Jayant Rajgopal; Bryan A Norman; Sheng-I Chen; Shawn T Brown; Rachel B Slayton; Souleymane Kone; Hailu Kenea; Joel S Welling; Diana L Connor; Angela R Wateska; Anirban Jana; Ann E Wiringa; Willem G Van Panhuis; Donald S Burke
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

2.  Rethinking global access to vaccines.

Authors:  Dave A Chokshi; Aaron S Kesselheim
Journal:  BMJ       Date:  2008-04-05

3.  Infectious disease management: lessons from cuba.

Authors:  Noni E Macdonald; Beth Halperin; Enrique Beldarrain Chaple; Jeff Scott; John M Kirk
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-07       Impact factor: 2.471

4.  Comparative cost models of a liquid nitrogen vapor phase (LNVP) cold chain-distributed cryopreserved malaria vaccine vs. a conventional vaccine.

Authors:  Cristina Reyes Garcia; Fatuma Manzi; Fabrizio Tediosi; Stephen L Hoffman; Eric R James
Journal:  Vaccine       Date:  2012-11-10       Impact factor: 3.641

Review 5.  Systems vaccinology: a promise for the young and the poor.

Authors:  Nelly Amenyogbe; Ofer Levy; Tobias R Kollmann
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

6.  Single-cell analysis of innate cytokine responses to pattern recognition receptor stimulation in children across four continents.

Authors:  Philip J Cooper; Monika Esser; Arnaud Marchant; Kinga K Smolen; Bing Cai; Edgardo S Fortuno; Laura Gelinas; Martin Larsen; David P Speert; Mustapha Chamekh; Tobias R Kollmann
Journal:  J Immunol       Date:  2014-08-18       Impact factor: 5.422

7.  The potential impact of immunization campaign budget re-allocation on global eradication of paediatric infectious diseases.

Authors:  Tiffany Fitzpatrick; Chris T Bauch
Journal:  BMC Public Health       Date:  2011-09-28       Impact factor: 3.295

8.  How a New Health Intervention Affects the Health Systems? Learnings from Pentavalent Vaccine Introduction in India.

Authors:  Chandrakant Lahariya; Renu Paruthi; Madhulekha Bhattacharya
Journal:  Indian J Pediatr       Date:  2015-08-13       Impact factor: 1.967

9.  Variation between Populations in the Innate Immune Response to Vaccine Adjuvants.

Authors:  Tobias R Kollmann
Journal:  Front Immunol       Date:  2013-04-02       Impact factor: 7.561

Review 10.  Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators.

Authors:  Elke S Bergmann-Leitner; Wolfgang W Leitner
Journal:  Vaccines (Basel)       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.